The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Drug Delivery > Oculex Pharmaceuticals, Inc.

Oculex Pharmaceuticals, Inc.
 PROFILE
Here's drug in your eye. Oculex Pharmaceuticals develops pharmaceuticals for ophthalmological treatments using a drug-delivery system which enables implantation of drugs in the eye. The company's lead product candidates are Surodex, which treats eye inflammation following cataract surgery, and Posurdex, for inflammation following vitreal and retinal surgeries. Other products in the works are targeted at glaucoma surgery, corneal transplant rejection, and various post-surgical infections. Oculex has partnered with Bausch & Lomb to market Surodex and also has a research collaboration with Allergan.

 COMPETITION
Akorn, Inc. (AKRN)
Escalon Medical Corp. (ESMC)
ISTA Pharmaceuticals, Inc. (ISTA)

 FINANCIAL OVERVIEW
Fiscal Year-End: December
1999 Sales (mil.): 0.20
1-Yr. Sales Growth: 65.8%
Employees: 59
Revenue per employee: $3,389.83

 KEY PEOPLE
• Donald J. Eaton
    CEO
• Douglas Hawkins
    CFO

 CONTACT INFO
601 W. California Ave
Sunnyvale, CA 94086
US
Phone: 408-481-0424
Fax: 408-481-0662
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001